Condensed Statement of Shareholders' Deficiency - USD ($)	3 Months Ended		9 Months Ended
	Oct. 31, 2019	Oct. 31, 2018	Oct. 31, 2019	Oct. 31, 2018
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)			1,233,853
Beginning Balance	$ (716,824)	$ (635,008)	$ (678,551)	$ (595,602)
Net loss	$ (89)	(16,685)	$ (38,362)	(56,091)
Ending Balance (in shares)	1,233,853		1,233,853
Ending Balance	$ (716,913)	$ (651,693)	$ (716,913)	$ (651,693)
Common Stock
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Beginning Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Ending Balance (in shares)	1,233,853	1,233,853	1,233,853	1,233,853
Ending Balance	$ 1,233	$ 1,233	$ 1,233	$ 1,233
Additional Paid-in Capital
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	81,323	81,323	81,323	81,323
Ending Balance	81,323	81,323	81,323	81,323
Accumulated Deficit
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Beginning Balance	(799,380)	(717,564)	(761,107)	(678,158)
Net loss	(89)	(16,685)	(38,362)	(56,091)
Ending Balance	$ (799,469)	$ (734,249)	$ (799,469)	$ (734,249)